1-197510832-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001195215.2(DENND1B):c.1956C>T(p.Ser652=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0016 in 1,612,090 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0088 ( 19 hom., cov: 32)
Exomes 𝑓: 0.00084 ( 17 hom. )
Consequence
DENND1B
NM_001195215.2 synonymous
NM_001195215.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.48
Genes affected
DENND1B (HGNC:28404): (DENN domain containing 1B) Clathrin (see MIM 118955)-mediated endocytosis is a major mechanism for internalization of proteins and lipids. Members of the connecdenn family, such as DENND1B, function as guanine nucleotide exchange factors (GEFs) for the early endosomal small GTPase RAB35 (MIM 604199) and bind to clathrin and clathrin adaptor protein-2 (AP2; see MIM 601024). Thus, connecdenns link RAB35 activation with the clathrin machinery (Marat and McPherson, 2010 [PubMed 20154091]).[supplied by OMIM, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 1-197510832-G-A is Benign according to our data. Variant chr1-197510832-G-A is described in ClinVar as [Benign]. Clinvar id is 788637.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.48 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00884 (1342/151776) while in subpopulation AFR AF= 0.0301 (1248/41460). AF 95% confidence interval is 0.0287. There are 19 homozygotes in gnomad4. There are 607 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DENND1B | NM_001195215.2 | c.1956C>T | p.Ser652= | synonymous_variant | 23/23 | ENST00000620048.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DENND1B | ENST00000620048.6 | c.1956C>T | p.Ser652= | synonymous_variant | 23/23 | 5 | NM_001195215.2 | P2 | |
DENND1B | ENST00000294737.11 | c.*644C>T | 3_prime_UTR_variant, NMD_transcript_variant | 20/20 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00883 AC: 1339AN: 151658Hom.: 19 Cov.: 32
GnomAD3 genomes
AF:
AC:
1339
AN:
151658
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00235 AC: 588AN: 249852Hom.: 6 AF XY: 0.00169 AC XY: 228AN XY: 135024
GnomAD3 exomes
AF:
AC:
588
AN:
249852
Hom.:
AF XY:
AC XY:
228
AN XY:
135024
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000843 AC: 1231AN: 1460314Hom.: 17 Cov.: 31 AF XY: 0.000739 AC XY: 537AN XY: 726442
GnomAD4 exome
AF:
AC:
1231
AN:
1460314
Hom.:
Cov.:
31
AF XY:
AC XY:
537
AN XY:
726442
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00884 AC: 1342AN: 151776Hom.: 19 Cov.: 32 AF XY: 0.00818 AC XY: 607AN XY: 74174
GnomAD4 genome
AF:
AC:
1342
AN:
151776
Hom.:
Cov.:
32
AF XY:
AC XY:
607
AN XY:
74174
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at